ADVERTISEMENT

Sun Pharma, Nykaa, Deepak Nitrite, Ramco Cements, Metropolis, Star Cement Q4 Results Review: HDFC Securities

Sun Pharma guides for high-single-digit revenue growth in FY25 on steady growth across the business.

<div class="paragraphs"><p>Stock chart is dislpayed on a monitor. (Source: Unsplash)</p></div>
Stock chart is dislpayed on a monitor. (Source: Unsplash)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit